Axogen posts Nov 9, 2026 investor deck for prostate nerve reconstruction event; no financials disclosed

Axogen, Inc.

Axogen published a corporate presentation dated November 9, 2026 to ir.axogeninc.com tied to a 'Prostate Nerve Reconstruction Investor Event' held that day.
Exhibit 99.1 as furnished contains only the deck's title/cover text; no revenue, EPS, guidance, or pipeline data appears in the filing.
Company states the presentation may be used from time to time in conversations with analysts and investors under Regulation FD.
No executives, directors, deal terms, or clinical results are named anywhere in the filing or exhibit text.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.